Curis, Inc. CRIS, today
announced the appointment of Robert Martell, M.D., Ph.D., to its Board of
Directors. Dr. Martell is currently the Director of the Neely Center for
Clinical Cancer Research and the Leader of the Program in Experimental
Therapeutics at the Tufts Medical Center Cancer Center as well as an Associate
Professor of Medicine at the Tufts University School of Medicine.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in